ArticleCell reports. Medicine2021

Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.

Dongqing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.